Skip to content

H2020FP7HORIZON

Sanofi-Aventis Deutschland GmbH

Country
DEGermany
Projects
38
As coordinator
3
EU contribution (CORDIS)
EUR 3,007,443
Active
2009 to 2025

Projects

38 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
PIAPhotocatalytic Industrial ApplicationsHORIZON2025ParticipantEUR 521,078
CHITOCATDevelopment of Chitosan-based Immobilized Catalysts for H/D Exchange in Continuous Flow SystemsHORIZON2025Associated partnerEUR 0
MC4DDMacrocycles for Drug DiscoveryHORIZON2024ParticipantEUR 260,539
NHPigReducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig ModelsHORIZON2024Associated partnerEUR 0
ISOBIOTICSIsotopic Labeling of BiotherapeuticsHORIZON2023ParticipantEUR 521,078
AiRPaDDAdvancing Reaction Platforms for Drug DiscoveryHORIZON2023ParticipantEUR 260,539
EDENT1FIEuropean action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease InterceptionHORIZON2023ParticipantEUR 0
RealHOPEReal World Handling of Protein Drugs - Exploration, Evaluation and EducationH20202021ParticipantEUR 0
INNODIA HARVESTTranslational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIAH20202020ParticipantEUR 0
ImmUniverseBetter control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsiesH20202020ParticipantEUR 0
BIOMAPBiomarkers in Atopic Dermatitis and PsoriasisH20202019ParticipantEUR 0
ESCulabEuropean Screening Centre; Unique Library for Attractive BiologyH20202018ParticipantEUR 0
Hypo-RESOLVEHypoglycaemia - REdefining SOLutions for better liVEsH20202018ParticipantEUR 0
iConsensusIntegrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and productionH20202018ParticipantEUR 0
LITMUSLiver Investigation: Testing Marker Utility in SteatohepatitisH20202017ParticipantEUR 0
eTRANSAFEEnhacing TRANslational SAFEty Assessment through Integrative Knowledge ManagementH20202017ParticipantEUR 0
IB4SD-TRISTANImaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106H20202017ParticipantEUR 0
RTCureRheuma Tolerance for CureH20202017ParticipantEUR 0
BEAt-DKDBiomarker Enterprise to Attack DKD - Sofia ref.: 115974H20202016ParticipantEUR 0
RHAPSODYAssessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881H20202016ParticipantEUR 0

The country is the one the source records for the organisation’s registration (its PIC). A body with sites in several countries is recorded under one of them, which is not always its legal seat: the Spanish research council CSIC, for example, appears under Italy. The data holds no country per site, so we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.